These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2323812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane.
    Sypek JP, Wyler DJ.
    J Exp Med; 1991 Oct 01; 174(4):755-9. PubMed ID: 1680956
    [Abstract] [Full Text] [Related]

  • 5. Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense.
    Birkland TP, Sypek JP, Wyler DJ.
    J Leukoc Biol; 1992 Mar 01; 51(3):296-9. PubMed ID: 1347312
    [Abstract] [Full Text] [Related]

  • 6. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 01; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

  • 7. Antigen recognition by effector T cells in antileishmanial defense.
    Sypek JP, Panosian CB, Wyler DJ.
    J Infect Dis; 1985 Nov 01; 152(5):1057-63. PubMed ID: 2413143
    [Abstract] [Full Text] [Related]

  • 8. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
    Panosian CB, Sypek JP, Wyler DJ.
    J Immunol; 1984 Dec 01; 133(6):3358-65. PubMed ID: 6208278
    [Abstract] [Full Text] [Related]

  • 9. Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC.
    Sypek JP, Wyler DJ.
    Clin Exp Immunol; 1985 Dec 01; 62(3):449-57. PubMed ID: 3936653
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of lymphokine-resistant Leishmania to cell contact-mediated macrophage activation.
    Sypek JP, Wyler DJ.
    J Infect Dis; 1988 Aug 01; 158(2):392-7. PubMed ID: 3136211
    [Abstract] [Full Text] [Related]

  • 11. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
    Liew FY, Millott S, Li Y, Lelchuk R, Chan WL, Ziltener H.
    Eur J Immunol; 1989 Jul 01; 19(7):1227-32. PubMed ID: 2503386
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).
    Van Niel A, Zacks SE, David JR, Remold HG, Weiser WY.
    Adv Exp Med Biol; 1988 Jul 01; 239():231-7. PubMed ID: 3059767
    [Abstract] [Full Text] [Related]

  • 13. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
    Titus RG, Kelso A, Louis JA.
    Clin Exp Immunol; 1984 Jan 01; 55(1):157-65. PubMed ID: 6198115
    [Abstract] [Full Text] [Related]

  • 14. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL, Lazdins JK, Hieny S, Natovitz P.
    J Immunol; 1983 Sep 01; 131(3):1481-6. PubMed ID: 6350456
    [Abstract] [Full Text] [Related]

  • 15. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW, De Weger RA, Vandebriel RJ, Den Otter W.
    Immunobiology; 1989 Jun 01; 179(2-3):131-44. PubMed ID: 2676851
    [Abstract] [Full Text] [Related]

  • 16. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    Davis CE, Belosevic M, Meltzer MS, Nacy CA.
    J Immunol; 1988 Jul 15; 141(2):627-35. PubMed ID: 3133412
    [Abstract] [Full Text] [Related]

  • 17. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA.
    J Immunol; 1984 Jul 15; 133(1):448-53. PubMed ID: 6202789
    [Abstract] [Full Text] [Related]

  • 18. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U, Krammer PH.
    Eur J Immunol; 1985 Jan 15; 15(1):18-24. PubMed ID: 3917924
    [Abstract] [Full Text] [Related]

  • 19. Functional analysis of macrophage hybridomas. II. Antibody-independent tumor cytotoxicity and its dissociation from IL-1 production and Ia expression.
    Liu YN, Uchida T, Ju ST, Dorf ME.
    Cell Immunol; 1985 Apr 15; 92(1):142-53. PubMed ID: 3935332
    [Abstract] [Full Text] [Related]

  • 20. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
    Nacy CA, Meltzer MS, Fortier AH.
    J Immunol; 1984 Dec 15; 133(6):3344-50. PubMed ID: 6491291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.